Concentrates his practice on corporate restructurings in Chapter 11 cases and out-of-court restructurings.
Seventeen years of experience advising on restructurings across all industries, with a particular focus on retail and energy.

Arik Preis represents informal and official committees of creditors, debtors, individual creditors, rights offering backstoppers, and lenders in in-court and out-of-court restructurings. He has also represented lenders and administrative agents in connection with non-restructuring-related loans, including leveraged loan transactions, mezzanine financings and more traditional loans.

Arik’s work extends to the representation of creditors in the analysis of all types of debt documents and capital structures.

Clients describe Arik as “very detail orientated and very creative” with a “very strong command of client relationships and an ability to finesse tough issues with his constituents to achieve the most beneficial outcome possible.”

Representative Work

Rite Aid: Counsel to the Official Committee of Tort Claimants in connection with the chapter 11 cases of Rite Aid Corporation, one of the many co-defendants alleged to have been responsible for the opioid crisis.
Endo International: Counsel to the Official Committee of Opioid Claimants in the chapter 11 cases of Endo International and its affiliates, an American-Irish generics and specialty branded pharmaceutical company, involving hundreds of billions of dollars of asserted claims.
Mallinckrodt: Counsel to the Official Committee of Opioid Related Claimants in the chapter 11 cases of Mallinckrodt and its affiliates, an American-Irish pharmaceuticals company, involving hundreds of billions of dollars of asserted claims. Restructuring of the Year (The Deal).
Purdue Pharma: Counsel to the Official Committee of Unsecured Creditors in the chapter 11 cases of Purdue Pharma and its affiliates, the privately held pharmaceutical company and maker of OxyContin, involving over a trillion dollars of asserted claims.
Insys Therapeutics: Counsel to the Official Committee of Unsecured Creditors in the chapter 11 cases of Insys Therapeutics and its affiliates, an American specialty pharmaceutical company, involving nearly $1 billion in liabilities.

HONX: Counsel to the Official Committee of Unsecured Creditors in the chapter 11 case of HONX, a subsidiary of Hess Oil, that owned and operated a refinery in the U.S. Virgin Islands, involving hundreds of millions of dollars of potential asbestos liabilities.
Boy Scouts of America: Special Counsel to the Coalition of Abused Scouts of Justice, in the chapter 11 cases of Boy Scouts of America.
Achaogen: Counsel to the Official Committee of Unsecured Creditors in the chapter 11 case of Achaogen, a biopharmaceutical company developing and commercializing innovative antibacterial agents, involving $120 million in liabilities. Cross-Border M&A Deal of the Year – Below $50M (Turnaround Atlas Awards).
Pernix : Counsel to the Official Committee of Unsecured Creditors in the chapter 11 cases of Pernix Therapeutics and its affiliates, a specialty pharmaceutical company. Chapter 11 Reorganization of the Year – $50M to $100M (M&A Advisor).

Education
J.D., University of Virginia School of Law, 2000
B.A., Wesleyan University, with honors, 1997

Bar Admissions
New York

Recognitions

Chambers USA, Bankruptcy/Restructuring, 2016 – 2024.
Law360, Bankruptcy MVP, 2022.
Best Lawyers in America, Bankruptcy and Creditor Debtor Rights / Insolvency and Reorganization Law, 2021 – 2023.
Turnarounds & Workouts, Outstanding Restructuring Lawyers, 2021.
The Legal 500, Restructuring (Including Bankruptcy): Corporate, 2020 and 2023.
IFLR1000 US, Restructuring, 2019.
Law360, Rising Star, 2015.
Turnarounds & Workouts, Outstanding Young Restructuring Lawyers, 2013.

Affiliations and Public Service

Member, UJA-Federation of New York’s Lawyers Division, Bankruptcy and Reorganization Group (Next Generation).

Speeches and Publications

“The Boy Scouts of America (BSA) Chapter 11: The Intersection of Mass Torts and Bankruptcy”, Panelist, ABI's Strategies and Perspectives Webinar, May 2024.
“Non-Debtor Releases and the Implications,” Panelist, George Washington University Law Bench and Bar Conference, New York, April 2024.
“3rd Party Releases,” Panelist, Annual AIRA and NYIC’s Luncheon Program, New York, January 2024.
“Bankruptcy v. MDL Strategy: The Multi-Year Payout Impact,” Panelist, Mass Torts Vendor Association’s Trial Lawyers Summit, Miami, January 2024.
“Bankruptcy and Mass Torts”, Panelist, Federal Bar Council, New York, November 2022.
“The Resolution of Tort Liabilities Through Bankruptcy”, Panelist, AIRA‘s Annual Advanced Restructuring and Plan of Reorganization Conference, November 2021.
“The Opioid Crisis”, Panelist, ABI’s New York City Bankruptcy Conference, New York, May 2021.
“Mass Tort Bankruptcies”, Panelist, University of Texas Bankruptcy Conference, Austin, November 2020.
“Mass Torts in Bankruptcy”, AIRA‘s Annual Advanced Restructuring and Plan of Reorganization Conference, November 2019.
“LLC Bankruptcies”, Moderator, ABI’s New York City Bankruptcy Conference, New York, May 2019.
“Analyzing Potential MNPI Disclosure Issues in Bankruptcy,” Panelist, Wharton Restructuring and Distressed Investing Conference, New York, February 2019.
“Distressed M&A Transactions,” Panelist, Akin Deal Maker’s Boot Camp, New York, 2014, 2018.
“Determining Privilege in Insolvency & Restructuring Matters”, Panelist, New York City Bar, October 2013.